Tag: NLR.C
-
Pubcos extending warrants as summer drags on, hoping for cash injection in months ahead
Canadian-listed, German-based bioscience accelerator BioNxt (BNXT.C) has announced it plans to give warrant holders an additional year to exercise 2022-purchased $0.50 warrants of the company, as its stock steadily climbs up from a low of $0.20 to $0.305 over the past week. BioNxt is going through an FDA trial process on a new oral film…
-
Northern Lights Resources (NLR.C) market cap is a silver lining and golden opportunity for investors
I have a confession to make. You see, I like silver stocks, but they’re very rarely cheap enough for me. More specifically, there’s one stock I’ve been eyeing for a number of months that is super interesting but isn’t yet (and maybe will never be) a screaming buy. Reason being, I like dirt cheap stocks…